Tuesday, April 5, 2022 marked a momentous day for Jupiter Wellness (NASDAQ:JUPW) as they announced the launch of their groundbreaking proprietary line of innovative sunscreen, NoStingz.

Investors will be watching closely to see if Jupiter Wellness stock is investment-worthy following the new product launch. Jupiter Wellness stock could move depending on NoStingz long-term availability, market acceptance and overall success. 


Read more to learn more about NoStingz, other Jupiter Wellness news and potential effects on Jupiter Wellness’ share price.

 

What is NoStingz?

NoStingz is a new product in Jupiter Wellness’s proprietary sunscreen line designed to protect users against jellyfish and man o’ war stings, sea lice, and swimmer’s itch. In addition, it also protects ocean lovers’ skin from harmful UVA/UVB in a range of SPFs.

Jupiter Wellness developed NoStingz as part of its partnership with Shark Defense Technologies LLC. The agreement gives Jupiter Wellness exclusive worldwide intellectual property rights to Shark Defense Technologies formulas and production methods for jellyfish protective compounds. It also guarantees future collaborations between both companies to develop and refine additional formulas. 

NoStingz is especially important for global ocean lovers, beach-goers and tourists who would otherwise face physical danger due to Jellyfish and other common sea creatures. The U.S. National Foundation estimates that 150 million people get stung by jellyfish yearly. About 200,000 of those stings occur in Florida. In addition, scientists believe there is an increasing number of jellyfish each year, meaning more bites and stings for future swimmers. 

A jellyfish’s sting can cause intense pain, swelling, itching, and tentacle print marks. These notorious stings can also lead to breathing difficulties and potentially fatal heart problems.

NoStingz was designed to provide a reliable line of defense, and potentially save hundreds of lives each year. The product line includes sprays and lotion for kids and adults, with more SKUs to be added. NoStingz’s dermatologically tested, hypoallergenic, scientifically proven, waterproof formula prevents stings from most jellyfish and sea lice. It also gives sunray and UV protection and comes packaged in a biodegradable bottle that is harmless to the marine environment.

Beach

Is Jupiter Wellness a buy following NoStingz’s launch? 

The future looks bright for Jupiter Wellness following its partnership with Shark Defense Technologies LLC. 

The partnership is already becoming fruitful. Besides the launch of NoStringz, Jupiter Wellness also launched CaniSun for Shark Defense Sunscreen, a product that will protect ocean lovers from unprovoked shark attacks. Undoubtedly, even more products are on the horizon, helping Jupiter Wellness rally revenue gains in the coming year. 

Investors are also optimistic about the rise of the global sun care market. Worth $13 billion in 2019 and estimated to rise to $17 billion by 2027, the global sun care market is steadily growing. Investors willing to buy and hold pioneering companies in the suncare industry could reap large rewards on their investments in the coming years. 

Conclusion

As of 10:17 AM EDT on Monday, April 19, 2022, Jupiter Wellness was trading at $1.0350, up by 1.47% from its previous close of $1.02 per share. The company’s market capitalization is $23.189 million. 

Jupiter Wellness has announced plans to continuously expand its market reach and revenue share of the global suncare, CBD and other wellness industries through innovative product launches like NoStingz. Jupiter Wellness looks well on course for an increase in its share price and stock market portfolio in 2022-2023 as it continues to develop innovative products and strike strategic partnerships.

Want to learn more about Jupiter Wellness and see if we think it’s a buy? Click here to read our JUPW stock review and alert page. 

Beat The Market With Our Expert Stock Picks

If you invested in 10 of our featured stock picks over the last 5 years, your chances of beating the market would be 90%.

Our last 3 stock picks grew a combined 348% after our alert!

Want to be notified the next time we issue a “Big Buy” alert or update our stocks to buy list? Sign up below today.

 Get Our Top Stock Picks Sent To You Each Week!
We respect your email privacy
displays
Sony Stock Pops on Hiked PS5 Prices

Sony Stock Pops on Hiked PS5 Prices

Sony Corporation (NYSE: SONY) announced a price hike for its flagship PlayStation 5 console in multiple international markets, citing inflationary pressures and the general economic environment.    As a result, shares gained about 2% to bounce off the intra-week...

read more
Salesforce Stock Plunges on Weak Results

Salesforce Stock Plunges on Weak Results

Shares of Salesforce (NYSE: CRM) are down almost 7% in premarket trading Thursday despite the company reporting better-than-expected Q2 earnings per share (EPS) and revenue. However, CRM provided weak guidance for 2023, hence a move down in aftermarket hours on...

read more
Fed Chair Powell Spooks Markets – What’s Next?

Fed Chair Powell Spooks Markets – What’s Next?

Equities saw a steep decline on Friday after Federal Reserve Chairman Jerome Powell reiterated the central bank’s commitment to bringing down inflation by continuing to hike interest rates that could cause “some pain” to the U.S. economy.    At the long-standing...

read more
Best Stocks to Buy in August-September 2022

Best Stocks to Buy in August-September 2022

August 31, 2022, NetApp, Inc. (NASDAQ:NTAP) and ServiceNow, Inc. (NYSE:NOW) These important tech names are the best stocks to buy now after unreasonably falling after solid earnings. You can say whatever you want about tech at the moment. It’s oversaturated, hates...

read more
Why Did Novavax (NVAX) Stock Tumble This Week

Why Did Novavax (NVAX) Stock Tumble This Week

Shares of Novavax (NASDAQ: NVAX) have plunged over this week after the company significantly reduced its full-year revenue forecast as it no longer expects fresh coronavirus vaccine sales for 2022 in the U.S.    Guiding Down   Novavax trimmed its 2022 sales...

read more
What to Expect from Fed Chair Powell in Jackson Hole

What to Expect from Fed Chair Powell in Jackson Hole

Federal Reserve Chair Jerome Powell shared his views this week about the prospects and possible headwinds for the U.S. economy, which continues to grapple with record-high inflation and a potential recession.    The head of the U.S. central bank does not know...

read more
Breaking Down Warren Buffet’s New Investments

Breaking Down Warren Buffet’s New Investments

Warren Buffet’s Berkshire Hathaway (NYSE: BRK.A) has tripled its stake in Ally Financial and increased its holdings in the video game maker Activision Blizzard, betting on its deal with Microsoft Corp, new filings showed.   What is Warren Buffet Buying?  ...

read more
Best Stocks to Buy Now [August 30, 2022]

Best Stocks to Buy Now [August 30, 2022]

August 30, 2022, UiPath Inc. (NYSE:PATH) and Snowflake Inc. (NYSE:SNOW) With inflation fears still a major concern for the market, consider these “deflation enablers” the best stocks to buy now.   Inflation remains an evident concern for the market. Fed Chair Jay...

read more
Best Stocks to Buy Now [August 29, 2022]

Best Stocks to Buy Now [August 29, 2022]

August 29, 2022, Westlake Corporation (NYSE: WLK) and Phillips 66 (NYSE: PSX) With energy costs soaring in the U.K. and Europe and chemicals in constant global demand, these two companies are the best stocks to buy now.   Investors were not blasting Ice Cube’s...

read more

Disclaimer: Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.